Daniel Miller

Daniel Miller is an experienced oncology drug discovery leader with 15 years in cancer research. They completed their PhD in Biology at the Massachusetts Institute of Technology, where they studied mammary gland development and stem cell differentiation. Daniel began their career as a Research Assistant at Brown University, focusing on the phosphatase PTP1B. They held various positions in the industry, including Principal Scientist at Cyteir Therapeutics, where they led oncology target identification and validation, and are currently the Associate Director at AstraZeneca in Early Oncology R&D.